immune checkpoint inhibitors

Tuebingen, Germany — August 26, 2026 HepaRegeniX GmbH announced that the U.S. FDA has granted Orphan Drug Designation (ODD)...

Lawrenceville, New Jersey – August 26, 2026 IMUNON announced plans to host its 2026 R&D Day on September 23...

Fort Myers, Florida – August 26, 2026 NeoGenomics announced that its RaDaR ST molecular residual disease (MRD) assay has...

MADISON, Wis. – July 24, 2026 Elephas Biosciences Corporation has unveiled new preclinical data demonstrating that its elive™ functional...

Lyon, France, January 20, 2026 — MaaT Pharma, a late-stage clinical biotechnology company developing microbiome-driven immunotherapies, announced that the...